Perrigo (PRGO) Stock
Global manufacturer of medicines and baby formulas. Here's the price, business snapshot, and what's worth knowing about Perrigo in August 2026.
Perrigo Company plc (PRGO) is a global consumer healthcare manufacturer best known for over‑the‑counter medicines, infant formulas and private‑label personal care products sold through supermarkets, pharmacies and online retailers. With a market capitalisation around $3.02 billion, Perrigo blends manufacturing scale with long‑term retailer relationships and a focus on branded and store‑brand consumer goods. Investors should note the company’s exposure to retail channels, commodity and input‑costs, and regulatory oversight that can affect margins and product launches. Perrigo has pursued portfolio reshaping and cost measures in recent years to stabilise margins, but sales and profits can fluctuate with pricing pressure, competition and supply‑chain disruption. This summary is for educational purposes only and not personalised investment advice; past performance is not a reliable indicator of future returns and suitability depends on your circumstances.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Perrigo's stock with a target price of $25.5, indicating potential growth.
Financial Health
Perrigo has strong revenue and cash flow, indicating good financial stability and performance.
Dividend
Perrigo's dividend yield of 5.78% is appealing for those seeking income from their investments. If you invested $1000 you would be paid $57.80 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Private‑label strength
Perrigo’s long relationships with retailers support steady sales in store‑brand products, though pricing pressure can squeeze margins.
Global distribution reach
A broad footprint gives scale and channel diversity, but exposes the company to currency, regulatory and regional demand risks.
Margins and costs
Operating profits are sensitive to input and freight costs; cost control helps, yet performance can vary with macro and supply‑chain shifts.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
